DAL MASO, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.059
EU - Europa 267
AS - Asia 182
OC - Oceania 3
Totale 1.511
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.059
IT - Italia 137
SG - Singapore 96
CN - Cina 62
SE - Svezia 36
DE - Germania 21
FR - Francia 16
FI - Finlandia 14
RU - Federazione Russa 14
GB - Regno Unito 12
IN - India 11
NL - Olanda 4
TW - Taiwan 4
AU - Australia 3
PL - Polonia 3
CH - Svizzera 2
ES - Italia 2
HK - Hong Kong 2
IE - Irlanda 2
LT - Lituania 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
ID - Indonesia 1
IL - Israele 1
PK - Pakistan 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 1.511
Salva come PNG Salva come JPEG
Città #
Fairfield 179
Chandler 134
Santa Clara 79
Singapore 74
Ashburn 69
Woodbridge 56
Cambridge 55
Seattle 52
Houston 50
Padova 45
Ann Arbor 36
Wilmington 32
Boardman 30
San Diego 27
Medford 17
Princeton 17
Beijing 14
Des Moines 13
Helsinki 13
New York 13
Milan 12
Roxbury 11
Columbus 8
Pune 8
Ogden 7
London 6
Rome 6
Dallas 4
Hsinchu County 4
Arzignano 3
Frankfurt am Main 3
Guangzhou 3
Munich 3
Naples 3
Treviso 3
Turin 3
Washington 3
Amsterdam 2
Arezzo 2
Belluno 2
Bologna 2
Brescia 2
Brisbane 2
Castagnole 2
Cerro al Lambro 2
Dublin 2
Duncan 2
Fort Worth 2
Gdansk 2
Genoa 2
Grisignano di Zocco 2
Hong Kong 2
Jinan 2
Los Angeles 2
Lucca 2
Milazzo 2
Nettuno 2
Parma 2
Pignone 2
Portland 2
Southwark 2
Ahmedabad 1
Ankara 1
Bari 1
Bellaterra 1
Castelfranco di Sotto 1
Changsha 1
Chicago 1
Florence 1
Groningen 1
Gunzenhausen 1
Hanover 1
Hounslow 1
Jolanda di Savoia 1
Kharkiv 1
Kilburn 1
Lahore 1
Lappeenranta 1
Leuven 1
Lower Saxony 1
Maida Vale 1
Marostica 1
Melbourne 1
Metairie 1
Modena 1
Nagercoil 1
Nanchang 1
Norwalk 1
Pisa 1
Ras al-Khaimah 1
San Floriano del Collio 1
San Francisco 1
Savignano sul Panaro 1
Seregno 1
Shanghai 1
Shenyang 1
Surat 1
Tashkent 1
Tel Aviv 1
Torreglia 1
Totale 1.182
Salva come PNG Salva come JPEG
Nome #
Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter? 128
Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors 118
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome 102
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy 90
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study 81
51P Liver kinase B1 (LKB1) and phosphorylated AMP kinase (AMPK) expression in small cell lung cancer (SCLC): Association with prognosis and tumour immune microenvironment (TIME) features 77
Clinical features and progression pattern of T790M+ compared with T790M-EGFR mutant NSCLC 76
149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW) 75
Novel Nuclear Medicine Imaging Applications in Immuno-Oncology 73
1398P Real-life progression (PD) pattern of EGFR mutant advanced non-small cell lung cancer (aNSCLC) patients (pts) receiving systemic therapy after first- or second-generation tyrosine kinase inhibitor (1-2 gen TKI) 73
SRC and PIM1 as potential co-targets to overcome resistance in MET deregulated non-small cell lung cancer 70
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines 69
Circulating biomarkers and risk of immune-related adverse events (irAEs) in patients (pts) with advanced non-small cell lung cancer (aNSCLC) and metastatic melanoma (mMel) 68
Detection of Low-Frequency KRAS Mutations in cfDNA From EGFR-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase Inhibitors 67
119P The role of circulating markers in predicting immune-related adverse events (irAEs) and their recurrence in advanced non-small cell lung cancer (aNSCLC) patients (pts) 66
Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome 58
EGFR T790M testing through repeated liquid biopsy over time: a real-world multicentric retrospective experience 37
Trifluridine/Tipiracil (TAS-102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program 37
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg? 28
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting 26
The role of liver kinase B1 in small cell lung cancer: association with prognosis and tumor immune microenvironment features 22
The Multidisciplinary Approach in Stage III Non-Small Cell Lung Cancer over Ten Years: From Radiation Therapy Optimisation to Innovative Systemic Treatments 19
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis 18
Tissue and circulating biomarkers of benefit to immunotherapy in extensive-stage small cell lung cancer patients 18
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines 17
Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysis 15
The emerging role of Schlafen-11 (SLFN11) in predicting response to anticancer treatments: Focus on small cell lung cancer 11
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World 11
Totale 1.550
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.651
article - articoli 8.597
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.248
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202046 0 0 0 0 0 0 6 9 10 6 11 4
2020/2021180 9 4 14 2 1 14 36 12 17 15 8 48
2021/2022384 19 43 54 9 26 52 60 9 13 18 25 56
2022/2023270 31 39 15 38 31 21 5 20 53 6 11 0
2023/2024264 21 21 27 28 17 40 18 24 21 13 22 12
2024/2025316 4 69 46 34 135 17 11 0 0 0 0 0
Totale 1.550